Literature DB >> 2990192

Terminal duct carcinoma of minor salivary glands. A nonpapillary subtype of polymorphous low-grade adenocarcinoma.

H F Frierson, S E Mills, T A Garland.   

Abstract

The clinicopathologic features of five terminal duct carcinomas arising in minor salivary glands are presented. These nonpapillary, low-grade adenocarcinomas are part of the spectrum of polymorphous low-grade adenocarcinoma. The patients ranged in age from 47 to 77 years. Symptoms were nonspecific and related to a mass that usually was present for several years. Histologically, the tumors had a ductal pattern with areas of solid and cribriform architecture. Cytologically, they were composed of uniform, cuboid cells with round to oval nuclei and fine chromatin. One patient developed a recurrence after 13 years, but none of the tumors has metastasized. One lesion in this series was studied ultrastructurally and demonstrated both glandular and pseudoglandular structures analogous to those of adenoid cystic carcinoma. Nonetheless, terminal duct carcinoma is cytologically distinctive from adenoid cystic carcinoma and appears to have a more favorable prognosis.

Entities:  

Mesh:

Year:  1985        PMID: 2990192     DOI: 10.1093/ajcp/84.1.8

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Authors:  Justin A Bishop; Raluca Yonescu; Denise Batista; Shahnaz Begum; David W Eisele; William H Westra
Journal:  Hum Pathol       Date:  2013-06-14       Impact factor: 3.466

2.  Vimentin as a marker of myoepithelial cells in salivary gland tumors.

Authors:  V C de Araújo; N S de Araújo
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

3.  Prognosis of salivary adenocarcinomas. A retrospective study of 52 cases with special regard to cytochemically assessed nuclear DNA content.

Authors:  K Hamper; M Brügmann; J Caselitz; H Arps; J Berger; U Askensten; G Auer; G Seifert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.

Authors:  Lisa Rooper; Rajni Sharma; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2014-06-27

5.  Argyrophilia in nucleolar organizer regions (AgNOR) in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of the salivary glands.

Authors:  R A Freitas; V C de Araújo; N S Araújo
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.